MARK2 and metabolic syndrome: In contrast, in a single family with a loss-of-function mutation in the serine threonine kinase AKT2, a critical more distal component in insulin signaling, affected patients had a severe phenocopy of the prevalent metabolic syndrome, encompassing severe fatty liver, dyslipidemia, and suppressed plasma adiponectin (9).